Home » Newsletters » BioWorld Science

BioWorld Science

March 19, 2013

View Archived Issues

Receptos licenses RPC-4046 from AbbVie

NAT2 study finds prevention of exudative age-related macular degeneration with DHA/EPA

Modified western blot assay detects Plasmodium circumsporozoite protein

Personal Genome Diagnostics licenses rights to genome mapping technology

ANAVEX 2-73 protects against Abeta25-35 toxicity in Alzheimer's disease mouse models

Biomaterial for prevention of heart failure found safe, effective in preclinical studies

OG-L002 helps demonstrate role of LSD1 in regulation of HSV infection

Improved tolerability of tolterodine/pilocarpine fixed-dose combination without loss of efficacy

Japanese scientists divulge novel PDE10A inhibitors

Hyperuricemia therapy patented by Kissei Pharmaceutical

Novel antipsychotic drugs reported by Merck & Co.

Trimel reports pivotal phase III data for CompleoTRT

Novel O-GlcNAcase inhibitors disclosed in Germany

Novo Nordisk reports data from phase IIIa liraglutide study

Long-term fingolimod treatment of relapsing-remitting MS proven safe in FREEDOMS II extension study

MethylGene reports data from phase II MGCD-290 trial

PI3K inhibitors disclosed by GlaxoSmithKline

FDA grants orphan drug status to a recombinant fusion protein and an AAV-G6Pase vector

Alnylam begins phase I ALN-TTRsc trial in TTR-mediated amyloidosis

Virobay and LEO Pharma begin phase I trial of VBY-891

Supplemental BLA submitted to expand Adcetris use in U.S.

Pegasys receives E.U. approval for HCV in children 5 years of age and older

Regen BioPharma receives FDA IND number for HemaXellerate

Bioradar targets Replikin increase in antibiotic-resistant bacterial strains, in vaccine strategy

FDA clears Quidel and Life Technologies products

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...